Tweet
The Province |
Put a lid on 'Low-T' drug use, FDA panel advises, threatening AbbVie, Lilly meds FiercePharma The testosterone-drug party may be over. An FDA advisory panel wants to limit their use for safety reasons--and the proposed restrictions would shrink sales significantly. That's not good news for AbbVie ($ABBV), the market leader, and other drugmakers that ... Testosterone Drugs May Need Further Study on Heart RiskFinancial Advisor Magazine FDA Panel: Limit Testosterone Drug UseU.S. News & World Report Panel pressures FDA, regarding testosterone drugsKGNS.tv NBCNews.com -Bidness ETC all 156 news articles » |
More...